Glen Eagle Advisors, LLC Alcon Inc Transaction History

Glen Eagle Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Jul 03, 2024	BUY	$74.84 - $88.15 $748 - $881	10 New	10 $830,000
Q4 2022 Aug 13, 2024	SELL	$56.51 - $71.71 $847 - $1,075	-15 Closed	0 $0
Q4 2020 Aug 13, 2024	BUY	$56.82 - $66.57 $284 - $332	5 Added 50.0%	15 $990,000
Q2 2020 Aug 13, 2024	SELL	$49.45 - $64.16 $296 - $384	-6 Reduced 28.57%	15 $860,000
Q1 2020 Aug 13, 2024	SELL	$39.86 - $63.46 $1,594 - $2,538	-40 Reduced 65.57%	21 $1.07 Million
Q4 2019 Aug 13, 2024	BUY	$55.04 - $59.27 $330 - $355	6 Added 10.91%	61 $3.45 Million
Q3 2019 Aug 13, 2024	SELL	$58.2 - $62.42 $232 - $249	-4 Reduced 6.78%	55 $3.21 Million
Q2 2019 Aug 13, 2024	BUY	$54.43 - $63.33 $2,667 - $3,103	49 Added 490.0%	59 $3.66 Million

729

242M

2.35M

1.65M

Ticker ALC
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 490,087,008
Market Cap $42.1B
Description
Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgi...

Get notified when there are updates to the investment portfolio of Glen Eagle Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Glen Eagle Advisors, LLC with notifications on news.